Exosens share sale

Agreement for the sale of 9.8% of Exosens’ share capital by HLD Europe to Theon International

PRESS RELEASE
MÉRIGNAC, FRANCE – 14 OCTOBER 2025

Sale price of €54 per Exosens share, underscoring the recognition of the Company’s unique strategic positioning as well as the strong growth potential identified by its largest night vision customer.

HLD Europe yesterday announced that it has entered into an agreement with Theon International, the Group’s main customer, for the sale of 9.8% of Exosens’ share capital (Euronext: EXENS; ISIN: FR001400Q9V2) at a price of €54 per share.

Jérôme Cerisier, CEO of Exosens, commented: " Theon's investment is a powerful recognition of the performance and reliability of Exosens technology – the very same technology that benefits our entire customer ecosystem. Our commitment to providing the same level of excellence and support to each of our partners in both our segments remains absolute."

The completion of the transaction, which remains subject to various regulatory notifications, is expected to take place in early Q1 2026. Upon completion of this transaction, HLD Europe will remain Exosens’ largest shareholder, holding 22.42% of the Company’s capital. Theon International will not be represented on the Company’s Board of Directors.

Exosens will pursue its development with the same commitment to excellence, innovation, and client focus that have driven its success to date.

Download Press Release

Investors relations :
Laurent Sfaxi, l.sfaxi@exosens.com

Medias contacts :
Brunswick Group – exosens@brunswickgroup.com
Laetitia Quignon, + 33 6 83 17 89 13
Nicolas Buffenoir, + 33 6 31 89 36 78